Latest Quarterly Financial Summary (H1 2026)
Wolters Kluwer reported its H1 2026 financial results on August 5, 2026. Total revenues reached €3,033 million, down 1% on a reported basis due to currency headwinds, but reflecting 4% growth in constant currencies and 5% organic growth.Recurring revenues (accounting for 85% of total) increased 7% organically, driven by strong momentum in cloud software, which grew 14% organically.
Adjusted operating profit rose 10% in constant currencies (3% reported) to €893 million, expanding the adjusted operating profit margin by 100 basis points to 29.4%.Diluted adjusted EPS grew 14% in constant currencies to €2.83.Adjusted free cash flow increased 14% in constant currencies to €533 million.The company reiterated its full-year 2026 guidance and declared an interim dividend of €1.01 per share.
Revenue Breakdown by Division and Geography
Division Breakdown
Wolters Kluwer reports revenue across five operating divisions:
- Health: Contributes ~23% of total revenue. Provides clinical decision support, medical research, and drug database software (e.g., UpToDate, Ovid, Lexidrug) to hospitals and healthcare providers.
- Tax & Accounting: Contributes ~33% of total revenue. Supplies tax compliance, auditing, and accounting software (e.g., CCH Axcess, CCH AnswerConnect) to professional firms and corporations.
- Financial & Corporate Compliance: Contributes ~14% of total revenue. Provides regulatory compliance, legal entity management, and lien services (e.g., CT Corporation, Lien Solutions).
- Legal & Regulatory: Contributes ~20% of total revenue. Offers legal research, compliance information, and legal workflow software (e.g., VitalLaw, Legisway) to law firms and corporate legal departments.
- Corporate Performance & ESG: Contributes ~10% of total revenue. Delivers corporate performance management, risk, internal audit, and ESG reporting platforms (e.g., CCH Tagetik, Enablon, TeamMate).
Geographic Revenue Distribution
- North America (~65% of total revenue):Serves as the primary growth engine, underpinned by high enterprise adoption of cloud solutions and GenAI extensions like UpToDate Expert AI.
- Europe (~27% of total revenue): Maintains steady demand driven by evolving tax, ESG, and EU regulatory standards, alongside digital software adoption.
- Asia Pacific & Rest of World (~8% of total revenue):Represents an expanding market focus with growing international activations across healthcare and corporate compliance platforms.
Quarter Changes, Key Watch Items, and Future Outlook
Operational Highlights & Recent Changes
During the period, Wolters Kluwer expanded the integration of artificial intelligence across its core divisions. In the Health division, over 90% of U.S. enterprise customers adopted UpToDate Expert AI, with international activation growing to over 230 sites across 36 countries. Product development spending was focused on generative AI enhancements across tax, legal, and compliance software portfolios.
Key Observation Points for Next Quarter
- Weighting of R&D Investments:Product development expenditure is planned to increase to 12%-13% of annual revenue, with investments heavily weighted toward H2 2026.
- Sales Cycle Velocity in ESG Solutions:Macroeconomic uncertainties have impacted enterprise decision cycles for Corporate Performance & ESG products.
- Capital Deployment:Execution of the up to €500 million share buyback program (€244 million executed in H1 2026).
Future Financial Outlook (Full-Year 2026 Guidance)
- Adjusted Operating Profit Margin:Expected at approximately 28.0% (FY 2025: 27.5%).
- Diluted Adjusted EPS:Targeted high single-digit growth in constant currencies.
- Adjusted Free Cash Flow:Projected between €1,300 million and €1,350 million.
- Return on Invested Capital (ROIC):Expected in the 18%-19% range.
Recent Stock Price Performance (Past 3 Months)
Over the past three months (May to August 2026), Wolters Kluwer NV (Euronext Amsterdam: WKL) traded in a range between approximately €58 and €74.
- May – June 2026: Shares experienced pressure, declining from ~€68 down toward a low of ~€58 in mid-June due to macro-driven sector rotations out of premium software valuations and broader European market volatility.
- July – August 2026: The stock recovered sharply, rising from ~€59 in mid-July to over €71 by late August.
Key Drivers:
- H1 Earnings Release: Strong organic recurring revenue (+7%) and operational margin expansion reported on August 5 reassured investors regarding core profitability and AI deployment traction.
- Share Buyback Execution: Continued progress on its €500 million share buyback program provided downward price support during broader market dips.
Information Sources
- https://www.wolterskluwer.com/en/news/wolters-kluwer-transforms-trusted-legal-content-into-structured-v2
- https://assets.contenthub.wolterskluwer.com/api/public/content/3775537-2026-08-05-wolters-kluwer-2026-half-year-results-7d85c04c6c?v=15135ed1
- https://www.taiwannews.com.tw/news/6415196
- https://www.trading212.com/trading-instruments/invest/WKL.NL
- https://stockinvest.us/stock/WKL.AS

Back to Wolters Kluwer
